Your browser doesn't support javascript.
loading
Novel expansion of a well-established antimicrobial stewardship program: Enhancing program efficiency and reach.
Wirtz, Ann L; Lee, Brian R; Burns, Alaina N; McDonough, Ryan J; Frank, Tammy S; Hall, Darrell E; Vanlandingham, Kate; Goldman, Jennifer L.
Afiliação
  • Wirtz AL; Department of Pharmacy Children's Mercy Kansas City, Kansas City, Missouri.
  • Lee BR; Division of Pediatric Infectious Diseases Children's Mercy Kansas CityKansas City, Missouri.
  • Burns AN; Department of Pharmacy Children's Mercy Kansas City, Kansas City, Missouri.
  • McDonough RJ; Medical Informatics Children's Mercy Kansas City, Kansas City, Missouri.
  • Frank TS; Medical Informatics Children's Mercy Kansas City, Kansas City, Missouri.
  • Hall DE; Medical Informatics Children's Mercy Kansas City, Kansas City, Missouri.
  • Vanlandingham K; Medical Informatics Children's Mercy Kansas City, Kansas City, Missouri.
  • Goldman JL; Division of Pediatric Infectious Diseases Children's Mercy Kansas CityKansas City, Missouri.
Infect Control Hosp Epidemiol ; 44(6): 869-874, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36039957
ABSTRACT

OBJECTIVE:

To evaluate efficiency and impact of a novel antimicrobial stewardship program (ASP) prospective-audit-with-feedback (PAF) review process using the Cerner Multi-Patient Task List (MPTL).

DESIGN:

Retrospective cohort study.

SETTING:

A 367-bed free-standing, pediatric academic medical center.

METHODS:

The ASP PAF review process expanded to monitor all systemic and inhaled antibiotics through use of the MPTL on July 23, 2020. Average number of daily ASP reviews, absolute number of monthly interventions, and time to conduct ASP reviews were compared between the preimplementation period and the postimplementation period following expansion. Antibiotic days of therapy (DOT) per 1,000 patient days for overall and select antibiotics were compared between periods. ASP intervention characteristics were assessed.

RESULTS:

Average daily ASP reviews significantly increased following program expansion (9 vs 14 reviews; P < .0001), and the absolute number of ASP interventions each month also increased (34 vs 52 interventions; P ≤ .0001). Time to conduct daily ASP reviews increased in the postimplementation period (1.03 vs 1.32 hours). Overall antibiotic DOT per 1,000 patient days significantly decreased in the postimplementation period (457.9 vs 427.9; P < .0001) as well as utilization of select, narrow-spectrum antibiotics such as ampicillin and clindamycin. Intervention type and antibiotics were similar between periods. The ASP documented 128 "nonantibiotic interventions" in the postimplementation period, including culture and/or susceptibility testing (32.8%), immunizations (25.8%), and additional diagnostic testing (22.7%).

CONCLUSIONS:

Implementation of an ASP PAF review process using the MPTL allowed for efficient expansion of a pre-existing ASP and a decrease in overall antibiotic utilization. ASP documentation was enhanced to fully track the impact of the program.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gestão de Antimicrobianos Tipo de estudo: Observational_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gestão de Antimicrobianos Tipo de estudo: Observational_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article